Psyllium versus fructooligosaccharide for improving bowel transit in women with functional constipation
Official title: Effects of Chronic Ingestion of Fructooligosaccharide and Psyllium on Intestinal Transit Time in Women Diagnosed With Functional Constipation: A Randomized, Crossover, Double-Blind Clinical Trial
Run by Federal University of Minas Gerais · NCT07202481 · Data updated 2026-11-12
This will test whether taking 20 g daily of psyllium or fructooligosaccharide for six days helps improve bowel movements and intestinal transit in adult women with functional constipation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 59 Years |
| Sex | Women only |
| Enrollment | 25 (estimated) |
| Sponsor | Federal University of Minas Gerais Academic / other |
| Locations | 1 site (Belo Horizonte, Minas Gerais) |
| Status | Recruiting |
| Started | March 14, 2026 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | March 24, 2026 |
| Trial ID | NCT07202481 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women aged 18–59 with functional constipation who currently consume less than about 25–30 g of fiber per day, are non-smokers, and have no other gastrointestinal disease are ideal candidates.
✕Probably not a fit
Patients with diabetes, significant thyroid disease, opioid use, prior surgery affecting gastrointestinal transit, delayed gastric emptying at baseline, or those already meeting adequate fiber intake may not receive benefit from these interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized crossover trial enrolls women aged 18–59 with functional constipation who consume less than recommended dietary fiber. Each participant will undergo 6-day periods of 20 g/day fiber (divided into two 10 g doses) with psyllium, fructooligosaccharide, and a control in random order, and will keep daily bowel and diet records. At the end of each period participants will have scintigraphic nuclear medicine imaging to measure intestinal transit, and laxatives are stopped before imaging. The crossover design allows within-person comparisons of effectiveness and side effects between the two fibers and control.
Why it matters
Potential benefit: If successful, the trial could identify which common fiber supplement more quickly improves bowel regularity and intestinal transit for women with functional constipation.
How similar studies have gone: Psyllium is well-supported by prior studies for relieving constipation and fructooligosaccharide has mixed evidence, so elements of this approach are established though direct short-term crossover comparisons with scintigraphy are less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Female participants aged 18-59 years. * Willingness to sign the Informed Consent Form . * No restrictions on the consumption of egg or gluten. * No history or diagnosis of gastrointestinal diseases other than functional constipation. * Non-smokers. * No use of prebiotics, probiotics, synbiotics, or antibiotics at least 10 days prior to the study. * No previous surgery affecting gastrointestinal transit. * Willingness to discontinue the use of laxatives at least 4 days prior to scintigraphic imaging. * Participants who do not consume adequate dietary fiber (25-30 g/day) as assessed by dietary recall. * No confirmed or suspected pregnancy during the study. * No self-reported menopause Exclusion Criteria * Diagnosis of diabetes, severe hyperthyroidism, or hypothyroidism. * Use of opioid medications. * Delayed gastric emptying at 4 hours during the placebo period (participants meeting this criterion will be excluded from final analysis).
Where it's running
-
School of Nursing, Federal University of Minas Gerais
Belo Horizonte, Minas Gerais, Brazil Recruiting
Study contacts
- Principal investigator: Simone de Vasconcelos Generoso, PhD — Department of Nutrition, Federal University of Minas Gerais
- Study coordinator: Simone de Vasconcelos Generoso, PhD
- Email: simonenutufmg@gmail.com
- Phone: 55(031) 988128650
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sacral nerve stimulation for children with bowel motility problems
This project tests sacral neuromodulation in children aged 3–18 with gastrointestinal motility disorders to see if imaging-guided, personalized implantation improves symptoms.
-
Fecal microbiota transplant with prebiotic nutrition for functional constipation
This will try fecal microbiota transplantation combined with a prebiotic nutrition plan to see if it helps adults aged 18–70 with chronic functional constipation that hasn’t improved with diet or laxatives.
-
Parents' views on physical activity for children aged 6-12 with functional constipation
Researchers will ask parents of children aged 6-12 with functional constipation about their child's physical activity to see if supporting exercise could help symptoms and care.
-
Diet-driven approach to ease constipation in people with Parkinson’s
A dietitian-guided nutritional plan is tested to see if it increases weekly bowel movements and improves gut health in adults with Parkinson’s disease and functional constipation.
-
Lactulose with or without a probiotic for constipation in adults with type 2 diabetes
This project will try lactulose, alone or combined with a probiotic, to see if it helps constipation and changes gut bacteria in adults with type 2 diabetes.
-
Evaluating brain connectivity in patients with refractory constipation
This study is trying to see how brain activity in people with stubborn constipation can help predict if they will respond well to fluoxetine and other treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.